Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Harvard Business School
Colorcon
Moodys
Baxter

Last Updated: June 29, 2022

Patent: 8,216,997


✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,216,997
Title:Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
Abstract: In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Inventor(s): Seehra; Jasbir (Lexington, MA), Pearsall; Robert Scott (Woburn, MA), Kumar; Ravindra (Acton, MA)
Assignee: Acceleron Pharma, Inc. (Cambridge, MA)
Application Number:12/856,420
Patent Claims:see list of patent claims

Details for Patent 8,216,997

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 06/01/1989 See Plans and Pricing 2029-08-13
Amgen, Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 See Plans and Pricing 2029-08-13
Amgen, Inc. PROCRIT epoetin alfa Injection 103234 See Plans and Pricing 2029-08-13
Amgen, Inc. ARANESP darbepoetin alpha Injection 103951 09/17/2001 See Plans and Pricing 2029-08-13
Amgen, Inc. ARANESP darbepoetin alpha Injection 103951 07/19/2002 See Plans and Pricing 2029-08-13
Amgen, Inc. ARANESP darbepoetin alpha Injection 103951 12/17/2002 See Plans and Pricing 2029-08-13
Amgen, Inc. ARANESP darbepoetin alpha Injection 103951 12/12/2003 See Plans and Pricing 2029-08-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Baxter
Mallinckrodt
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.